Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3786) 3786
Publication (204) 204
Newsletter (184) 184
Book Review (45) 45
Book / eBook (25) 25
Book Chapter (21) 21
Magazine Article (17) 17
Conference Proceeding (13) 13
Web Resource (7) 7
Newspaper Article (3) 3
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3148) 3148
photochemotherapy (2169) 2169
female (1649) 1649
male (1638) 1638
photochemotherapy - adverse effects (1506) 1506
index medicus (1362) 1362
photodynamic therapy (1257) 1257
cancer (1159) 1159
middle aged (1156) 1156
photochemotherapy - methods (1008) 1008
adult (977) 977
aged (934) 934
photosensitizing agents - therapeutic use (873) 873
dermatology (812) 812
treatment outcome (794) 794
care and treatment (679) 679
animals (665) 665
photosensitizing agents - adverse effects (551) 551
ophthalmology (518) 518
aged, 80 and over (423) 423
surgery (388) 388
psoriasis - drug therapy (380) 380
photosensitizing agents - administration & dosage (374) 374
puva therapy - adverse effects (366) 366
research (360) 360
oncology (343) 343
follow-up studies (330) 330
aminolevulinic acid - therapeutic use (318) 318
5-aminolevulinic acid (313) 313
adolescent (283) 283
mice (277) 277
macular degeneration (276) 276
light (274) 274
porphyrins - therapeutic use (271) 271
skin neoplasms - drug therapy (262) 262
prospective studies (259) 259
verteporfin (259) 259
retrospective studies (252) 252
health aspects (249) 249
choroidal neovascularization - drug therapy (247) 247
fluorescein angiography (239) 239
time factors (237) 237
therapy (226) 226
skin (223) 223
aminolevulinic acid - adverse effects (219) 219
aminolevulinic acid - administration & dosage (215) 215
combined modality therapy (212) 212
lasers (206) 206
psoriasis (201) 201
visual acuity (200) 200
biochemistry & molecular biology (190) 190
tumors (182) 182
analysis (180) 180
aminolevulinic acid - analogs & derivatives (179) 179
phototherapy (178) 178
administration, topical (171) 171
porphyrins - adverse effects (167) 167
usage (162) 162
photosensitizing agents - pharmacology (158) 158
choroidal neovascularization - etiology (156) 156
risk factors (154) 154
clinical trials (150) 150
pharmacology & pharmacy (149) 149
actinic keratosis (147) 147
biophysics (146) 146
ultraviolet rays - adverse effects (144) 144
young adult (144) 144
child (141) 141
efficacy (141) 141
fluorescence (135) 135
keratosis, actinic - drug therapy (133) 133
macular degeneration - drug therapy (133) 133
apoptosis (131) 131
in-vitro (129) 129
skin cancer (128) 128
antineoplastic agents - therapeutic use (125) 125
skin neoplasms - etiology (125) 125
eye diseases (124) 124
methoxsalen - adverse effects (123) 123
neovascularization (122) 122
ultraviolet rays (122) 122
dose-response relationship, drug (121) 121
dermatology & venereal diseases (120) 120
internal medicine (119) 119
tomography, optical coherence (119) 119
drug therapy (117) 117
extracorporeal photochemotherapy (117) 117
laser (117) 117
medical research (116) 116
chemotherapy (114) 114
hematology (114) 114
rats (113) 113
laser therapy (112) 112
choroidal neovascularization (111) 111
trial (111) 111
ranibizumab (110) 110
transplantation (110) 110
chronic disease (109) 109
visual acuity - physiology (109) 109
squamous-cell carcinoma (108) 108
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3792) 3792
German (87) 87
French (54) 54
Spanish (26) 26
Russian (25) 25
Chinese (15) 15
Japanese (9) 9
Polish (9) 9
Swedish (4) 4
Danish (3) 3
Hungarian (3) 3
Italian (3) 3
Turkish (3) 3
Finnish (2) 2
Korean (2) 2
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Adverse effects of topical photodynamic therapy
by Ibbotson, Sally Helen
Photodermatology, Photoimmunology & Photomedicine, ISSN 0905-4383, 06/2011, Volume 27, Issue 3, pp. 116 - 130
Background/purpose: Topical photodynamic therapy (PDT) is increasingly used in dermatology, particularly for the treatment of superficial non‐melanoma skin... 
adverse effects | pain | photodynamic therapy | Pain | Photodynamic therapy | Adverse effects | ALLERGIC CONTACT-DERMATITIS | RANDOMIZED-CONTROLLED-TRIAL | DELTA-AMINOLEVULINIC-ACID | DIFFERENT LIGHT-SOURCES | EROSIVE PUSTULAR DERMATOSIS | PROTOPORPHYRIN-IX FLUORESCENCE | DERMATOLOGY | NONMELANOMA SKIN-CANCER | 5-AMINOLEVULINIC ACID | FACIAL ACTINIC KERATOSES | BASAL-CELL CARCINOMAS | Pain - etiology | Photochemotherapy - adverse effects | Skin Neoplasms - therapy | Photochemotherapy - methods | Humans | Pain Management | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Adverse effects of topical photodynamic therapy: a consensus review and approach to management
by Ibbotson, S.H and Wong, T.H and Morton, C.A and Collier, N.J and Haylett, A and McKenna, K.E and Mallipeddi, R and Moseley, H and Rhodes, L.E and Seukeran, D.C and Ward, K.A and Mohd Mustapa, M.F and Exton, L.S
British Journal of Dermatology, ISSN 0007-0963, 04/2019, Volume 180, Issue 4, pp. 715 - 729
What's already known about this topic? Photodynamic therapy (PDT) is widely used in dermatology. Pain is the most well documented adverse effect. Methods of... 
ALLERGIC CONTACT-DERMATITIS | MULTIPLE ACTINIC KERATOSES | NONMELANOMA SKIN-CANCER | DELTA-AMINOLEVULINIC-ACID | BASAL-CELL CARCINOMA | EMITTING DIODE LIGHT | 5-PERCENT IMIQUIMOD CREAM | 2-STEP IRRADIANCE SCHEDULE | INGENOL MEBUTATE GEL | PROTOPORPHYRIN-IX FLUORESCENCE | DERMATOLOGY | Complications and side effects | Usage | Dysplasia | Analysis | Medical societies | Melanoma | Skin | Photochemotherapy | Cancer | Side effects | Prodrugs | Photodynamic therapy | Pain | Toxicity | Hypersensitivity | Irradiance | Management | Patients | Skin cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A randomized, double‐blind, placebo‐controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5‐aminolevulinic acid photodynamic therapy
by Vanaman Wilson, Monique J and Jones, Isabela T and Wu, Douglas C and Goldman, Mitchel P
Lasers in Surgery and Medicine, ISSN 0196-8092, 10/2017, Volume 49, Issue 8, pp. 738 - 742
Background and Objective: Following photodynamic therapy with 5-aminolevulinic acid (ALA-PDT), patients experience inflammation that may be partially... 
antihistamines | actinic keratosis | photodynamic therapy | photobiology | SURGERY | IMMUNITY | HUMAN SKIN | EFFICACY | HISTAMINE-RECEPTORS | DERMATOLOGY | MELANOMA | ACTINIC KERATOSES | REDUCES INFLAMMATION | Follow-Up Studies | Photosensitizing Agents - therapeutic use | Photochemotherapy - methods | Humans | Middle Aged | Keratosis, Actinic - prevention & control | Male | Photosensitizing Agents - adverse effects | Drug Eruptions - prevention & control | Administration, Cutaneous | Erythema - prevention & control | Erythema - etiology | Female | Edema - prevention & control | Drug Eruptions - etiology | Photochemotherapy - adverse effects | Double-Blind Method | Histamine H1 Antagonists, Non-Sedating - therapeutic use | Treatment Outcome | Aminolevulinic Acid - therapeutic use | Cetirizine - therapeutic use | Aminolevulinic Acid - adverse effects | Edema - etiology | Keratosis, Actinic - drug therapy | Aged | Histamine receptors | Antihistamines | Evaluation | Complications and side effects | Medical research | Histamine | Clinical trials | Medicine, Experimental | Photochemotherapy | Cancer | Edema | Erosion mechanisms | Photodynamic therapy | Discomfort | Inflammation | Cetirizine | Aminolevulinic acid | Side effects | Randomization | Acids | Lasers | Healing | Exudation | Receptor mechanisms | Pretreatment | Erythema | Erosion | Keratosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Adverse effects associated with photodynamic therapy (PDT) of port-wine stain (PWS) birthmarks
by Yuan, Kai-Hua and Gao, Jian-Hua, MD and Huang, Zheng
Photodiagnosis and Photodynamic Therapy, ISSN 1572-1000, 2012, Volume 9, Issue 4, pp. 332 - 336
Summary Background Several Chinese studies suggest that Hemoporfin-mediated photodynamic therapy (PDT) is an alternative treatment for port-wine stain (PWS)... 
Hematology, Oncology and Palliative Medicine | Internal Medicine | Adverse effect | Port-wine stains | Photodynamic therapy | PULSED-DYE-LASER | EFFICACY | ONCOLOGY | BURNS | CONJUNCTION | Photochemotherapy - adverse effects | Low-Level Light Therapy - adverse effects | Low-Level Light Therapy - methods | Photosensitizing Agents - therapeutic use | Hematoporphyrins - therapeutic use | Humans | Photosensitizing Agents - adverse effects | Lasers, Solid-State - adverse effects | Port-Wine Stain - radiotherapy | Lasers, Gas - adverse effects | China | Hematoporphyrins - adverse effects | Retrospective Studies | Photochemotherapy - statistics & numerical data | Skin - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Adverse effects associated with photodynamic therapy birthmarks
by Yuan, Kai-Hua and Gao, Jian-Hua and Huang, Zheng
Photodiagnosis and Photodynamic Therapy, ISSN 1572-1000, 12/2012, Volume 9, Issue 4, p. 332
Several Chinese studies suggest that Hemoporfin-mediated photodynamic therapy (PDT) is an alternative treatment for port-wine stain (PWS) birthmarks. 
Complications and side effects | Surgery, Plastic | Birthmarks | Photochemotherapy | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Optical interactions with tissues and cells XXI
: 25-27 January 2010, San Francisco, California, United States
by Jansen, E. Duco and Thomas, Robert J and United States. Air Force.Office of Scientific Research and SPIE (Society)
2010, Progress in biomedical optics and imaging, ISBN 0819479586, Volume 11, no. 15
Laser Therapy | adverse effects | Photochemotherapy
Web Resource
Details down arrow
7. Full Text Safety of UVA-Riboflavin Cross-Linking of the Cornea
by Spoerl, Eberhard and Mrochen, Michael and Sliney, David and Trokel, Stephen and Seiler, Theo
Cornea, ISSN 0277-3740, 05/2007, Volume 26, Issue 4, pp. 385 - 389
PURPOSE:To study potential damage to ocular tissue during corneal collagen cross-linking (X-linking) by means of the riboflavin/UVA (370 nm) approach.... 
Cornea | Keratectasia | Damage | Cross-linking | Keratoconus | Collagen | UV | damage | IN-SITU KERATOMILEUSIS | keratoconus | cornea | TISSUE | collagen | RADIATION-INDUCED CATARACT | keratectasia | THERAPY | cross-linking | ENDOTHELIUM | EXPOSURE TIME | OPHTHALMOLOGY | ULTRAVIOLET-RADIATION | CYTOTOXICITY | Cornea - radiation effects | Corneal Stroma - drug effects | Cross-Linking Reagents | Riboflavin - adverse effects | Free Radicals | Humans | Radiation Tolerance | Photosensitizing Agents - adverse effects | Endothelium, Corneal - drug effects | Photochemotherapy | Ultraviolet Rays - adverse effects | Collagen - radiation effects | Animals | Cornea - drug effects | Endothelium, Corneal - radiation effects | Collagen - drug effects | Corneal Stroma - radiation effects | Fibroblasts - radiation effects | Fibroblasts - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
by Brown, David M and Kaiser, Peter K and Michels, Mark and Soubrane, Gisele and Heier, Jeffrey S and Kim, Robert Y and Sy, Judy P and Schneider, Susan and ANCHOR Study Grp and ANCHOR Study Group
The New England Journal of Medicine, ISSN 0028-4793, 10/2006, Volume 355, Issue 14, pp. 1432 - 1444
Previous studies have implicated intravitreal vascular endothelial growth factor A (VEGF-A) as a target for countering neovascularization and, therefore,... 
MEDICINE, GENERAL & INTERNAL | PREVALENCE | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Macular Degeneration - drug therapy | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Visual Acuity - drug effects | Choroidal Neovascularization - drug therapy | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Porphyrins - therapeutic use | Double-Blind Method | Injections | Antibodies, Monoclonal - administration & dosage | Porphyrins - adverse effects | Aged | Macular Degeneration - pathology | Macular degeneration | Drug therapy | Care and treatment | Diabetic retinopathy | Photodynamic therapy | Older people | Aging | Eyes & eyesight | Vascular endothelial growth factor | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Everest study: Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy
by Koh, Adrian and Lee, Won Ki and Chen, Lee-Jen and Chen, Shih-Jen and Hashad, Yehia and Kim, Hakyoung and Lai, Timothy Y and Pilz, Stefan and Ruamviboonsuk, Paisan and Tokaji, Erika and Weisberger, Annemarie and Lim, Tock H
Retina, ISSN 0275-004X, 09/2012, Volume 32, Issue 8, pp. 1453 - 1464
Purpose: To assess the effects of verteporfin photodynamic therapy (PDT) combined with ranibizumab or alone versus ranibizumab monotherapy in patients with... 
angio-occlusion | indocyanine green angiography | verteporfin PDT | polyp regression | polypoidalchoroidal vasculopathy | confocal scanning laser ophthalmoscope | ranibizumab | polypoidal choroidal vasculopathy | SUBMACULAR HEMORRHAGE | DEGENERATION | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | NEOVASCULARIZATION | OUTCOMES | JAPANESE PATIENTS | Polyps - diagnosis | Intravitreal Injections | Photosensitizing Agents - therapeutic use | Coloring Agents | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Choroid Diseases - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Choroid Diseases - physiopathology | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Double-Blind Method | Choroid - blood supply | Indocyanine Green | Treatment Outcome | Combined Modality Therapy | Polyps - physiopathology | Polyps - drug therapy | Porphyrins - adverse effects | Aged | Choroid Diseases - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial
by Rubel, D.M and Spelman, L and Murrell, D.F and See, J.‐A and Hewitt, D and Foley, P and Bosc, C and Kerob, D and Kerrouche, N and Wulf, H.C and Shumack, S
British Journal of Dermatology, ISSN 0007-0963, 11/2014, Volume 171, Issue 5, pp. 1164 - 1171
What's already known about this topic? Methyl aminolevulinate conventional photodynamic therapy ( MAL c‐ PDT ) is effective for treating actinic keratosis ( AK... 
POPULATION | PREVALENCE | EXPOSURE | BASAL-CELL CARCINOMA | GUIDELINES | DERMATOLOGY | Photochemotherapy - adverse effects | Prospective Studies | Pain - prevention & control | Photochemotherapy - methods | Humans | Male | Photosensitizing Agents - adverse effects | Treatment Outcome | Facial Dermatoses - drug therapy | Facial Dermatoses - pathology | Administration, Cutaneous | Scalp Dermatoses - pathology | Aminolevulinic Acid - adverse effects | Aminolevulinic Acid - administration & dosage | Photosensitizing Agents - administration & dosage | Scalp Dermatoses - drug therapy | Keratosis, Actinic - drug therapy | Aminolevulinic Acid - analogs & derivatives | Aged, 80 and over | Female | Aged | Keratosis, Actinic - pathology | Ointments
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Interventions for Old World cutaneous leishmaniasis
by Heras-Mosteiro, Julio and Monge-Maillo, Begoña and Pinart, Mariona and Lopez Pereira, Patricia and Garcia-Carrasco, Emely and Campuzano Cuadrado, Pedro and Royuela, Ana and Mendez Roman, Irene and López-Vélez, Rogelio
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 11/2017, Volume 2017, Issue 11, p. CD005067
Background Cutaneous leishmaniasis, caused by a parasitic infection, is considered one of the most serious skin diseases in many low-and middle-income... 
MEDICINE, GENERAL & INTERNAL | AMINOSIDINE PAROMOMYCIN OINTMENT | LOCAL HEAT THERAPY | RANDOMIZED CLINICAL-TRIAL | AMPHOTERICIN-B AMBISOME(R) | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | TOPICAL PAROMOMYCIN | HYPERTONIC SODIUM-CHLORIDE | VISCERAL LEISHMANIASIS | INTRALESIONAL MEGLUMINE ANTIMONIATE | Hot Temperature - therapeutic use | Paromomycin - adverse effects | Anti-Infective Agents - adverse effects | Paromomycin - therapeutic use | Humans | Laser Therapy | Anti-Infective Agents - therapeutic use | Photochemotherapy | Randomized Controlled Trials as Topic | Itraconazole - therapeutic use | Complementary Therapies | Animals | Antiprotozoal Agents - adverse effects | Itraconazole - adverse effects | Leishmaniasis, Cutaneous - therapy | Leishmania tropica | Antiprotozoal Agents - therapeutic use | Cryotherapy | Leishmania major
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights